Xylem press release ( XYL ): Q4 Non-GAAP EPS of $1.42 beats by $0.01 . Revenue of $2.4B (+6.2% Y/Y) beats by $30M . Outlook Xylem forecasts full-year 2026 revenue of approximately $9.1 to $9.2 billion vs. $9.33B consensus , up approximately 1 to 3 percent on a reported basis and up approximately 2 to 4 percent on an organic basis. Full-year 2026 adjusted EBITDA margin is expected to be approximate...
Xylem press release ( XYL ): Q4 Non-GAAP EPS of $1.42 beats by $0.01 . Revenue of $2.4B (+6.2% Y/Y) beats by $30M . Outlook Xylem forecasts full-year 2026 revenue of approximately $9.1 to $9.2 billion vs. $9.33B consensus , up approximately 1 to 3 percent on a reported basis and up approximately 2 to 4 percent on an organic basis. Full-year 2026 adjusted EBITDA margin is expected to be approximately 22.9 to 23.3 percent, an increase of 70 to 110 basis points from Xylem’s 2025 adjusted results. Full-year free cash flow margin is expected to be approximately 10.2 to 11 percent. More on Xylem Xylem: A Secular Growth Within Water Xylem Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Xylem Historical earnings data for Xylem Dividend scorecard for Xylem
*Consensus source: Bloomberg More on CVS CVS Health: Exploit The Sector Panic Ahead Of Earnings CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript CVS Health Corporation (CVS) Analyst/Investor Day - Slideshow CVS Non-GAAP EPS of $1.09 beats by $0.09, revenue of $105.69B beats by $2.12B What to expect from CVS Q4 earnings
*Consensus source: Bloomberg More on CVS CVS Health: Exploit The Sector Panic Ahead Of Earnings CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript CVS Health Corporation (CVS) Analyst/Investor Day - Slideshow CVS Non-GAAP EPS of $1.09 beats by $0.09, revenue of $105.69B beats by $2.12B What to expect from CVS Q4 earnings
Company Logo AI in oncology is poised to revolutionize cancer care through early, accurate detection, and personalized treatment, driven by rising cancer rates. Key opportunities include AI-enhanced imaging, precision medicine, and drug development efficiencies. Growth is supported by technological advances and increasing market demand. Slide 1 Slide 1 · GlobeNewswire Inc. Slide 2 Slide 2 · GlobeN...
Company Logo AI in oncology is poised to revolutionize cancer care through early, accurate detection, and personalized treatment, driven by rising cancer rates. Key opportunities include AI-enhanced imaging, precision medicine, and drug development efficiencies. Growth is supported by technological advances and increasing market demand. Slide 1 Slide 1 · GlobeNewswire Inc. Slide 2 Slide 2 · GlobeNewswire Inc. Slide 3 Slide 3 · GlobeNewswire Inc. Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "AI in Oncology Market, till 2040: Distribution by Type of Cancer, Type of End User, and Geographical Regions: Industry Trends and Global Forecasts" report has been added to ResearchAndMarkets.com's offering. The global AI in oncology market size is estimated to grow from USD 2.7 billion in the current year to USD 17.3 billion by 2040, at a CAGR of 14.1% during the forecast period, till 2040. The new study provides information on market size, growth scenarios, industry trends and future forecasts. Given the rising incidence of cancer globally, there has been an increased demand for advanced diagnostic and treatment methods to care for patients. Artificial Intelligence (AI) is transforming oncology by improving cancer care at every stage of the patient's journey, from early detection through imaging and pathology analysis (such as mammograms and CT scans) to personalized treatment. It also aids in predicting patient outcomes, thereby enhancing efficiency, accuracy, and accessibility of care. AI in oncology market is expected to rise at a significant rate throughout the forecast period. This is due to urgent demand for early, accurate detection, the shift toward precision medicine, and the need for optimized, cost-effective treatment planning to manage a rising global cancer burden. Strategic Insights for Senior Leaders AI in Oncology Market: Competitive Landscape of Companies in this Industry The competitive landscape of AI in oncology market is characterized by intense competitio...
Coca-Cola press release ( KO ): Q4 Non-GAAP EPS of $0.58 beats by $0.02 . Revenue of $11.8B (+2.6% Y/Y) misses by $250M . For the quarter, net revenues grew 2% to $11.8 billion, and organic revenues (non-GAAP) grew 5%, driven by a 4% increase in concentrate sales and 1% growth in price/mix. Concentrate sales were 3 points ahead of unit case volume, driven by the timing of concentrate shipments and...
Coca-Cola press release ( KO ): Q4 Non-GAAP EPS of $0.58 beats by $0.02 . Revenue of $11.8B (+2.6% Y/Y) misses by $250M . For the quarter, net revenues grew 2% to $11.8 billion, and organic revenues (non-GAAP) grew 5%, driven by a 4% increase in concentrate sales and 1% growth in price/mix. Concentrate sales were 3 points ahead of unit case volume, driven by the timing of concentrate shipments and one additional day. For both the quarter and the full year, the company gained value share in total nonalcoholic ready-to-drink (“NARTD”) beverages. Shares -3.6% PM. More on Coca-Cola Coca-Cola Q4 Preview: No Hype, Just Quality The Coca-Cola Company: Slowing Spending By Lower-Income Individuals Is A Significant Red Flag Coca-Cola: Pricing Power Replaces Volume Growth Coca-Cola set to report Q4 earnings as 2026 guidance takes center stage Earnings week ahead: F, KO, CSCO, SHOP, MCD, BP, AMAT, COIN, MRNA, ROKU, and more
AlTi Global Inc. boosted its stake in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 30.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 52,220 shares of the electric vehicle producer's stock after purchasing an additional 12,111 shares during the period. Tesla comprises about 0.5% of AlTi Global Inc.'s investment portfoli...
AlTi Global Inc. boosted its stake in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 30.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 52,220 shares of the electric vehicle producer's stock after purchasing an additional 12,111 shares during the period. Tesla comprises about 0.5% of AlTi Global Inc.'s investment portfolio, making the stock its 29th biggest position. AlTi Global Inc.'s holdings in Tesla were worth $23,222,000 as of its most recent filing with the SEC. Other hedge funds have also bought and sold shares of the company. Brighton Jones LLC grew its holdings in Tesla by 11.8% during the 4th quarter. Brighton Jones LLC now owns 87,929 shares of the electric vehicle producer's stock valued at $35,509,000 after buying an additional 9,293 shares in the last quarter. Revolve Wealth Partners LLC grew its stake in Tesla by 21.2% during the fourth quarter. Revolve Wealth Partners LLC now owns 5,317 shares of the electric vehicle producer's stock valued at $2,147,000 after acquiring an additional 931 shares in the last quarter. Bison Wealth LLC increased its holdings in Tesla by 52.2% in the 4th quarter. Bison Wealth LLC now owns 10,368 shares of the electric vehicle producer's stock valued at $4,187,000 after acquiring an additional 3,558 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in Tesla by 9.1% in the 2nd quarter. Sivia Capital Partners LLC now owns 12,135 shares of the electric vehicle producer's stock worth $3,855,000 after purchasing an additional 1,011 shares in the last quarter. Finally, AGP Franklin LLC boosted its holdings in shares of Tesla by 21.2% during the 2nd quarter. AGP Franklin LLC now owns 4,861 shares of the electric vehicle producer's stock valued at $1,544,000 after purchasing an additional 851 shares during the last quarter. Institutional investors own 66.20% of the company's stock. Get Tesla alerts: Sign Up Tesla Trading Up 1.5% ...
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops. Today's guests: Andrea Orcel, UniCredit, CEO; Arend Kapteyn, UBS Investment Bank, Global Head of Economics & Strategy Research; Jim O'N...
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops. Today's guests: Andrea Orcel, UniCredit, CEO; Arend Kapteyn, UBS Investment Bank, Global Head of Economics & Strategy Research; Jim O'Neill, UK House of Lords, Member; Leslie Vinjamuri, Chicago Council on Global Affairs, President & CEO. Corrects to say 'Takaichi Trade' in graphic at 22:38. (Source: Bloomberg)
US equity futures waver ahead of retail sales data after tech stocks pushed the S&P 500 near a record high. Alphabet kicks off its global bond spree with sterling and Swiss franc-denominated bonds for the first time, including a 100-year note. TSMC posts a 37% jump in revenue for January. Seema Shah of Principal Asset Management discusses the AI disruption in stocks. Munich Security Council Chair ...
US equity futures waver ahead of retail sales data after tech stocks pushed the S&P 500 near a record high. Alphabet kicks off its global bond spree with sterling and Swiss franc-denominated bonds for the first time, including a 100-year note. TSMC posts a 37% jump in revenue for January. Seema Shah of Principal Asset Management discusses the AI disruption in stocks. Munich Security Council Chair Wolfgang Ischinger joins ahead of the conference set to begin on Friday. Correction: The interview with Munich Security Council Chair Wolfgang Ischinger was not exclusive. (Source: Bloomberg)
Ukraine Launching Arms Exports At Centers Across Europe Ukraine has another money-making idea - instead of begging for urgently needed funds from Western partners, it plans to start exporting weapons, instead of only buying them. But there is a big and unexpected catch to the whole scheme. Flush with external funding connected to the war with Russia, President Volodymyr Zelensky has announced ambi...
Ukraine Launching Arms Exports At Centers Across Europe Ukraine has another money-making idea - instead of begging for urgently needed funds from Western partners, it plans to start exporting weapons, instead of only buying them. But there is a big and unexpected catch to the whole scheme. Flush with external funding connected to the war with Russia, President Volodymyr Zelensky has announced ambitious plans to open ten arms export hubs across the European continent by the end of 2026 . Given Ukraine is still an active warzone, and given the likelihood that Russian forces will continue targeting defense manufacturing sites, Ukraine is seeking to have European allies play host to Ukrainian arms production plants . Ukrainian made Vulkan assault rifle, via Wiki Commons For example, Ukrainian-made drones are expected to be in production on German soil later this month. Zelensky laid out new details of Ukraine's move into foreign arms markets, describing it as a long-term economic necessity, in a speech before the Kyiv Aviation Institute on Sunday night. Ukraine's defense sector rapidly grown as a result of the war, accounting for roughly 7% of GDP, according to July 2025 estimates from the Kyiv School of Economics Institute. "Today we are opening up exports. In Europe in 2026 there will be 10 export centers. These are the Baltic countries and the countries of Northern Europe. In 2026, 10 representative offices will operate," Zelensky said, as quoted in Reuters . "This is a [production] line that is already working. The production lines are already operating in the UK. These are Ukrainian technologies," Zelensky added - though without providing much more in the way of specifics. In essence, Ukraine is seeking to sustain its war effort while locking in a long-term economic leverage by expanding its defense production sector, but in a protected and safe way far from the front lines. Simultaneously, Moscow has complained that Ukraine is already deep in the black market expo...
By Kirstin Ridley and Elizabeth Howcroft LONDON, Feb 10 - Britain's markets regulator said on Tuesday it had asked social media companies and app stores to block access to crypto exchange HTX in the UK. The Financial Conduct Authority, which filed a lawsuit against HTX in October accusing it of unlawfully promoting crypto asset services to UK consumers, said Tuesday it had asked Alphabet's Goog...
By Kirstin Ridley and Elizabeth Howcroft LONDON, Feb 10 - Britain's markets regulator said on Tuesday it had asked social media companies and app stores to block access to crypto exchange HTX in the UK. The Financial Conduct Authority, which filed a lawsuit against HTX in October accusing it of unlawfully promoting crypto asset services to UK consumers, said Tuesday it had asked Alphabet's Google and Apple to remove HTX products from UK app stores, and asked social media companies to block HTX's accounts to UK-based consumers. HTX, whose owners were not identified in the lawsuit, did not immediately respond to a request for comment. The crypto exchange, which appears on a warning list by the UK regulator for potentially promoting financial products without permission, repeatedly issued illegal crypto promotions to British consumers, the regulator said. FIRM HAS 'AN OPAQUE ORGANISATIONAL STRUCTURE' Regulators and authorities around the world have for years warned that nascent crypto markets - which are generally less regulated than mainstream financial markets - present risks to investors. "HTX operates an opaque organisational structure, hiding the identities of its owners and the operators of its website," the FCA said, adding that repeated attempts to engage with the company had been ignored. The regulator said HTX had taken steps to restrict new UK customers from registering accounts, but that existing UK users could log in and access unlawful financial promotions. HTX, formerly known as Huobi, was founded in 2013 and names Chinese crypto entrepreneur Justin Sun as a global adviser. Sun was not named in the lawsuit. Steve Smart, joint executive director of enforcement and market oversight at the FCA, said this was the first time the regulator had taken such enforcement action against a crypto firm for illegal marketing of products to UK consumers. (Reporting by Kirstin Ridley and Elizabeth Howcroft, additional reporting by Muvija M.; Editing by Be...